GPCR19 agonist (TDCA) efficacy and mode of action in atopic dermatitis and rosacea
用户Mp9ryMXiT0kM
11天前
27
10
已完结
1. 系统已在2026-01-01 16:06:18对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
아지즈
2025
s-space.snu.ac.kr
… Topical and oral TDCA treatment ameliorates proinflammatory features of AD in mice induced by DNCB, MC903, or oxazolone, as well as proinflammatory features of rosacea in the LL-…

